These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38956334)

  • 1. Streamlined collaboration can boost CRISPR gene therapies for rare diseases.
    He W; Zeng S; Xu C
    Nature; 2024 Jul; 631(8019):28. PubMed ID: 38956334
    [No Abstract]   [Full Text] [Related]  

  • 2. Cure Rare Disease: An Initiative to Enable N of 1 Gene Editing.
    Horgan RW
    Hum Gene Ther; 2023 Oct; 34(19-20):980-981. PubMed ID: 37823804
    [No Abstract]   [Full Text] [Related]  

  • 3. Writing the Story of Gene Editing and CRISPR: An Interview with Kevin Davies, PhD.
    Flotte TR
    Hum Gene Ther; 2020 Dec; 31(23-24):1217-1220. PubMed ID: 33337270
    [No Abstract]   [Full Text] [Related]  

  • 4. CRISPR/Cas9-mediated genome editing: From basic research to translational medicine.
    Jacinto FV; Link W; Ferreira BI
    J Cell Mol Med; 2020 Apr; 24(7):3766-3778. PubMed ID: 32096600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare genetic disorders in India: Current status, challenges, and CRISPR-based therapy.
    Bhattacharyya P; Mehndiratta K; Maiti S; Chakraborty D
    J Biosci; 2024; 49():. PubMed ID: 38383973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The CRISPR-Cas system: beyond genome editing].
    Croteau FR; Rousseau GM; Moineau S
    Med Sci (Paris); 2018 Oct; 34(10):813-819. PubMed ID: 30451675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A revealing flaw.
    Leslie M
    Science; 2021 Feb; 371(6530):663-665. PubMed ID: 33574194
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent Advances in Therapeutic Genome Editing in China.
    Yang Y; Wang Q; Li Q; Men K; He Z; Deng H; Ji W; Wei Y
    Hum Gene Ther; 2018 Feb; 29(2):136-145. PubMed ID: 29446996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How CRISPR gene editing could help treat Alzheimer's.
    Thompson T
    Nature; 2024 Jan; 625(7993):13-14. PubMed ID: 38082131
    [No Abstract]   [Full Text] [Related]  

  • 10. CRISPR/Cas9 gene-editing: Research technologies, clinical applications and ethical considerations.
    Memi F; Ntokou A; Papangeli I
    Semin Perinatol; 2018 Dec; 42(8):487-500. PubMed ID: 30482590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of heritable diseases using CRISPR: Hopes, fears, and reality.
    Kofler N; Kraschel KL
    Semin Perinatol; 2018 Dec; 42(8):515-521. PubMed ID: 30420296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic and diagnostic relevance of Crispr technology.
    El Ouar I; Djekoun A
    Biomed Pharmacother; 2021 Jun; 138():111487. PubMed ID: 33774312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical cutting edge.
    Nat Biotechnol; 2020 Jul; 38(7):767. PubMed ID: 32641850
    [No Abstract]   [Full Text] [Related]  

  • 14. CRISPR: History and perspectives to the future.
    Kozovska Z; Rajcaniova S; Munteanu P; Dzacovska S; Demkova L
    Biomed Pharmacother; 2021 Sep; 141():111917. PubMed ID: 34328110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. User-Friendly Technology the Key to Gene-Editing's Bloom: Market for Gene-Editing Tools Estimated at $608m and Growing as New Applications Are Found.
    Carlson B
    Hum Gene Ther Clin Dev; 2016 Dec; 27(4):137-139. PubMed ID: 27983891
    [No Abstract]   [Full Text] [Related]  

  • 16. The Future of Genome Editing.
    Cell; 2018 May; 173(6):1311-1313. PubMed ID: 29856947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR in personalized medicine: Industry perspectives in gene editing.
    Hong A
    Semin Perinatol; 2018 Dec; 42(8):501-507. PubMed ID: 30376985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of CRISPR/Cas9 gene editing technique in the study of cancer treatment.
    Jiang C; Meng L; Yang B; Luo X
    Clin Genet; 2020 Jan; 97(1):73-88. PubMed ID: 31231788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene editing based hearing impairment research and therapeutics.
    Kang W; Sun Z; Zhao X; Wang X; Tao Y; Wu H
    Neurosci Lett; 2019 Sep; 709():134326. PubMed ID: 31195050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CRISPR-Cas9 for muscle dystrophies].
    Ballouhey O; Bartoli M; Levy N
    Med Sci (Paris); 2020 Apr; 36(4):358-366. PubMed ID: 32356712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.